From: Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
 | Baseline | Exenatide | P value |
---|---|---|---|
Glucose metabolism variables | Â | Â | Â |
 AUC of plasma glucose [(mg/dL) · hr] | 855.4 ± 45.3 | 442.3 ± 26.4 | 0.001 |
 CV of plasma glucose | 0.19 ± 0.02 | 0.20 ± 0.01 | 0.776 |
 AUC of IRI [(μIU/mL) · hr] | 96.7 ± 18.5 | 84.6 ± 28.9 | 0.211 |
 CV of IRI | 0.49 ± 0.04 | 0.53 ± 0.05 | 0.427 |
Lipid metabolism variables | Â | Â | Â |
 AUC of TG [(mg/dL) · hr] | 616.8 ± 68.7 | 475.5 ± 45.7 | 0.001 |
 CV of TG | 0.14 ± 0.02 | 0.06 ± 0.02 | 0.001 |
 AUC of HDL-C [(mg/dL) · hr] | 171.8 ± 12.2 | 177.2 ± 13.4 | 0.064 |
 CV of HDL-C | 0.03 ± 0.003 | 0.03 ± 0.003 | 0.730 |
 AUC of LDL-C [(mg/dL) · hr] | 419.0 ± 35.1 | 436.3 ± 32.8 | 0.221 |
 CV of LDL-C | 0.03 ± 0.003 | 0.03 ± 0.003 | 0.875 |